These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12400464)

  • 1. What are club drugs? Here's a quick look.
    AIDS Alert; 2002 Oct; 17(10):123. PubMed ID: 12400464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brief overview of the clinical pharmacology of "club drugs".
    Britt GC; McCance-Katz EF
    Subst Use Misuse; 2005; 40(9-10):1189-201. PubMed ID: 16048813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Club drugs: is it all ecstasy?
    Tellier PP
    Pediatr Ann; 2002 Sep; 31(9):550-6. PubMed ID: 12271739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Tretter F
    Nervenarzt; 1997 Nov; 68(11):922-3. PubMed ID: 9732739
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Club drugs: reasons for and consequences of use.
    Parks KA; Kennedy CL
    J Psychoactive Drugs; 2004 Sep; 36(3):295-302. PubMed ID: 15559677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
    Gahlinger PM
    Am Fam Physician; 2004 Jun; 69(11):2619-26. PubMed ID: 15202696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Club drugs].
    Guerreiro DF; Carmo AL; da Silva JA; Navarro R; Góis C
    Acta Med Port; 2011; 24(5):739-56. PubMed ID: 22525626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GHB and synthetic cathinones: clinical effects and potential consequences.
    Karila L; Reynaud M
    Drug Test Anal; 2011 Sep; 3(9):552-9. PubMed ID: 21960540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.
    Goss J
    JEMS; 2001 Jun; 26(6):84-7, 90-3; quiz 94. PubMed ID: 11409205
    [No Abstract]   [Full Text] [Related]  

  • 11. The designer drug situation in Ibiza.
    Lora-Tamayo C; Tena T; Rodríguez A; Moreno D; Sancho JR; Enseñat P; Muela F
    Forensic Sci Int; 2004 Mar; 140(2-3):195-206. PubMed ID: 15036441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
    Wu LT; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2006 Sep; 84(1):102-13. PubMed ID: 16483730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new drugs: ecstasy, GHB. Update for practitioners].
    Feldman N; Croquette-Krokar M
    Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792
    [No Abstract]   [Full Text] [Related]  

  • 14. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.
    Smith KM; Larive LL; Romanelli F
    Am J Health Syst Pharm; 2002 Jun; 59(11):1067-76. PubMed ID: 12063892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men.
    Romanelli F; Smith KM; Pomeroy C
    Top HIV Med; 2003; 11(1):25-32. PubMed ID: 12717048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects and consequences of selected club drugs.
    Freese TE; Miotto K; Reback CJ
    J Subst Abuse Treat; 2002 Sep; 23(2):151-6. PubMed ID: 12220613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information from your family doctor. Club drugs--myths and risks.
    Am Fam Physician; 2004 Jun; 69(11):2627. PubMed ID: 15202697
    [No Abstract]   [Full Text] [Related]  

  • 18. A hyperthermic reaction to 'ecstasy'.
    Walsh T; Carmichael R; Chestnut J
    Br J Hosp Med; 1994 May 4-17; 51(9):476. PubMed ID: 7921506
    [No Abstract]   [Full Text] [Related]  

  • 19. Rave drugs: pharmacological considerations.
    Klein M; Kramer F
    AANA J; 2004 Feb; 72(1):61-7. PubMed ID: 15098519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health problems of designer drugs].
    Domínguez Carmona M; Rebato AM
    An R Acad Nac Med (Madr); 2003; 120(2):209-25; discussion 225-9. PubMed ID: 14619540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.